Novus Aurelius

UBS analyst Joshua Spector revised his stance on Methanex Corporation (NYSE: MEOH), elevating the rating from Neutral to Buy. Accompanying the upgrade, Spector increased the price objective from $51 to $60, indicating an 19.76% potential appreciation from the previous target.

Jefferies’ analyst Akash Tewari has issued a Buy rating on Apellis Pharmaceuticals Inc (ticker: APLS), signaling a confident outlook on the biotech firm's prospects. The revision escalates the price objective from $68 to $80, an appreciable 17.92% increase, underscoring Wall Street's recognition of the company's potential in the sector of complement inhibition therapeutics.

Jairam Nathan of Daiwa Capital articulated a positive stance on Rockwell Automation Inc (NYSE: ROK), issuing a Buy rating. The move reflects a pricing strategy recalibration, with the target set at $310—a revision from the earlier target of $338.